Universal Ibogaine Inc. (IBOGF)
OTCMKTS
· Delayed Price · Currency is USD
0.0183
+0.0005 (2.81%)
Jun 5, 2025, 11:34 AM EDT
Universal Ibogaine Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | 2019 |
| Revenue | 1.9 | 2.33 | 1.03 | 1.07 | - | - | Upgrade
|
| Revenue Growth (YoY) | -14.76% | 126.32% | -3.81% | - | - | - | Upgrade
|
| Cost of Revenue | 1.71 | 1.78 | 1.06 | 0.57 | - | - | Upgrade
|
| Gross Profit | 0.19 | 0.55 | -0.03 | 0.5 | - | - | Upgrade
|
| Selling, General & Admin | 0.87 | 1.04 | 1.61 | 3.66 | 3.8 | 2.34 | Upgrade
|
| Research & Development | 0.12 | 0.09 | 0.01 | 0.41 | - | 0.02 | Upgrade
|
| Operating Expenses | 1.3 | 1.45 | 2.02 | 5.24 | 3.86 | 3.37 | Upgrade
|
| Operating Income | -1.11 | -0.9 | -2.05 | -4.75 | -3.86 | -3.37 | Upgrade
|
| Interest Expense | -0.16 | -0.16 | -0.15 | -0.07 | -0.02 | -0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | -0.02 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | - | -0.01 | -0.13 | 0.03 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -1.29 | -1.06 | -2.22 | -4.94 | -3.87 | -3.45 | Upgrade
|
| Impairment of Goodwill | - | - | - | -1.46 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.98 | -0.98 | -0.36 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | -1.24 | - | -2.15 | Upgrade
|
| Other Unusual Items | -0 | -0 | - | -2.85 | - | 0.03 | Upgrade
|
| Pretax Income | -2.27 | -2.05 | -2.39 | -10.5 | -3.87 | -5.57 | Upgrade
|
| Net Income | -2.27 | -2.05 | -2.39 | -10.5 | -3.87 | -5.57 | Upgrade
|
| Net Income to Common | -2.27 | -2.05 | -2.39 | -10.5 | -3.87 | -5.57 | Upgrade
|
| Shares Outstanding (Basic) | 291 | 233 | 191 | 186 | 125 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 291 | 233 | 191 | 186 | 125 | 34 | Upgrade
|
| Shares Change (YoY) | 51.81% | 21.54% | 3.05% | 48.28% | 265.15% | 81.31% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.06 | -0.03 | -0.16 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.06 | -0.03 | -0.16 | Upgrade
|
| Free Cash Flow | -1.07 | -0.92 | -1.46 | -4.43 | -3.25 | -2.33 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.03 | -0.07 | Upgrade
|
| Gross Margin | 9.99% | 23.67% | -2.72% | 46.43% | - | - | Upgrade
|
| Operating Margin | -58.66% | -38.66% | -199.10% | -443.24% | - | - | Upgrade
|
| Profit Margin | -119.86% | -88.01% | -232.08% | -980.22% | - | - | Upgrade
|
| Free Cash Flow Margin | -56.63% | -39.35% | -141.50% | -413.60% | - | - | Upgrade
|
| EBITDA | -0.76 | -0.56 | -1.75 | -4.48 | -3.8 | -2.36 | Upgrade
|
| EBITDA Margin | -40.33% | -23.92% | -170.36% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.35 | 0.34 | 0.3 | 0.27 | 0.07 | 1 | Upgrade
|
| EBIT | -1.11 | -0.9 | -2.05 | -4.75 | -3.86 | -3.37 | Upgrade
|
| EBIT Margin | -58.66% | -38.66% | -199.10% | - | - | - | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 0.31 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.